14-66508555-A-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 0P and 0B.
The NM_020806.5(GPHN):c.28A>T(p.Asn10Tyr) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000234 in 1,613,786 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_020806.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000164 AC: 25AN: 152068Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000187 AC: 47AN: 251470Hom.: 0 AF XY: 0.000162 AC XY: 22AN XY: 135914
GnomAD4 exome AF: 0.000241 AC: 353AN: 1461718Hom.: 0 Cov.: 30 AF XY: 0.000224 AC XY: 163AN XY: 727176
GnomAD4 genome AF: 0.000164 AC: 25AN: 152068Hom.: 0 Cov.: 33 AF XY: 0.000135 AC XY: 10AN XY: 74296
ClinVar
Submissions by phenotype
Hyperekplexia 1 Pathogenic:1
- -
Sulfite oxidase deficiency due to molybdenum cofactor deficiency type C;C4551954:Hyperekplexia 1 Uncertain:1
- -
Inborn genetic diseases Uncertain:1
The c.28A>T (p.N10Y) alteration is located in exon 1 (coding exon 1) of the GPHN gene. This alteration results from a A to T substitution at nucleotide position 28, causing the asparagine (N) at amino acid position 10 to be replaced by a tyrosine (Y). This alteration was detected in a heterozygous patient presenting with neonatal hypertonia and excessive startle response. However, this patient was found at age four to have transient recovery of phenotype with no features of molybdenum metabolism disruption (Rees, 2003). The in silico prediction for the p.N10Y alteration is inconclusive. Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
not provided Uncertain:1
PP2, PM2 -
Hyperekplexia Uncertain:1
- -
Sulfite oxidase deficiency due to molybdenum cofactor deficiency type C Uncertain:1
This sequence change replaces asparagine, which is neutral and polar, with tyrosine, which is neutral and polar, at codon 10 of the GPHN protein (p.Asn10Tyr). This variant is present in population databases (rs121908539, gnomAD 0.03%). This missense change has been observed in individual(s) with neonatal hypertonia and hyperekplexia (PMID: 12684523). ClinVar contains an entry for this variant (Variation ID: 5973). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. Experimental studies have shown that this missense change does not substantially affect GPHN function (PMID: 12684523). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at